DCMIC
APGN

Decheng Capital Management III (Cayman)’s Apexigen, Inc. Common Stock APGN Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,894,551
Closed -$814K – 28
2023
Q2 		$814K Hold
1,894,551
– – 0.26% 23
2023
Q1 		$923K Hold
1,894,551
– – 0.37% 22
2022
Q4 		$1.29M Hold
1,894,551
– – 0.48% 21
2022
Q3 		$5.12M Buy
+1,894,551
New +$15.4M 1.85% 14

Decheng Capital Management III (Cayman)'s APGN Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 1,894,551 shares — an estimated $814K sold.

Decheng Capital Management III (Cayman) first reported a position in APGN in Q3 2022 and held it in 4 quarters. The position peaked at $5.12M in Q3 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Decheng Capital Management III (Cayman) reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Decheng Capital Management III (Cayman) sold 1,894,551 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $814K.
  • Decheng Capital Management III (Cayman) first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Decheng Capital Management III (Cayman)'s Apexigen, Inc. Common Stock position peaked at $5.12M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.